*Overview* We work within a highly entrepreneurial environment where personal effort and contributions are rewarded and where communication and teamwork…From… Click here to view original post
Bristol Myers Squibb disclosed Thursday at its R&D Day that it cut six programs, including mid-stage drug candidates for NASH and solid tumors. The New Jersey pharma company axed an siRNA for NASH, known as […]
Top of the morning to you. And a fine one it is. Lots of sunshine and clear blue skies are once again enveloping the Pharmalot campus, where the official mascots are bounding about the grounds […]
DVX201, a first-ever allogeneic, cord-blood derived, natural killer (NK) cell therapy, has been administered to 16 patients with no dose limiting toxicities, cytokine release syndrome or infusion toxicities to date at all dose levels WEXFORD, […]
AbbVie is walking away from an exclusive option for Harpoon’s BCMA-targeting T cell engager for multiple myeloma, leaving the California company to advance the asset alone. The agreement will end on Oct. 12, after which […]
RADNOR, Pa.–(BUSINESS WIRE)–Aclipse Therapeutics, and its subsidiary, Aclipse Two, Inc (“Aclipse”), an innovative biopharmaceutical company developing life-changing treatments for patients with severe diseases, announced today that it has signed an exclusive license agreement with Seoul, […]
Flagship Pioneering’s AI-focused startup Generate:Biomedicines has raised another megaround that will push multiple drug programs into the clinic. The Somerville, MA-based biotech said Thursday it has closed a $273 million Series C round bringing in […]
Job Title: Associate Scientist, Assay Development. Onsite or Hybrid with 4 days on-site. Pay range – $105K – 132K. Experience… Click here to view original post
The successful candidate will initiate an independent research project to explore new approach to characterize drug product for one of… Click here to view original post
Serving as a role model confronting racist, sexist, or other inappropriate actions by speaking up, challenging exclusionary organizational practices, and…From… Click here to view original post
Copyright © 2023 Biotech Networks, LLC
